TG Therapeutics, Inc. (TGTX)

31.35000 USD

0.65

2.03%

Last update Dec 12, 3:59 PM EST

Market closed

Day range

31.35000

31.14000

32.30200

Previous close

Open

32.16000

Access this stock data via API

TG Therapeutics, Inc.

31.35

0.65

2.03%

Earnings estimate	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Number of analysts	6	4	6	6
Average estimate	0.23	0.33	2.87	1.93
Low estimate	-0.17	0.23	2.44	1.31
High estimate	0.45	0.45	3.09	2.56
Last year EPS	0.15	0.03	0.15	2.87

Access /earnings_estimate data via our API — starting from the Ultra plan.

Revenue estimate	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Number of Analysts	8	5	8	8
Avg. estimate	182.38M	197.69M	606.03M	901.52M
Low estimate	176.90M	187.30M	600.60M	847.50M
High estimate	189.30M	209.50M	613M	955.86M
Last year sales	108.19M	120.86M	329.00M	606.03M
Sales growth	0.69	0.64	0.84	0.49

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS trend	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Current estimate	0.23	0.33	2.87	1.93
7 days ago	0.30	0.39	0.73	1.77
30 days ago	0.30	0.39	0.73	1.77
60 days ago	0.32	0.39	0.76	1.72
90 days ago	0.32	0.39	0.76	1.72

Access /eps_trend data via our API — starting from the Ultra plan.

EPS revisions	Current quarter (Dec 2025)	Next quarter (Mar 2026)	Current year (Dec 2025)	Next year (Dec 2026)
Up last 7 days	1	1	1	1
Up last 30 days	2	0	2	2
Down last 7 days	0	0	0	0
Down last 30 days	0	1	0	1

Access /eps_revisions data via our API — starting from the Ultra plan.

Access /growth_estimates data via our API — starting from the Ultra plan.

Access /analyst_ratings/light data via our API — starting from the Ultra plan.

TG Therapeutics, Inc.